You just read:

Regeneron and Sanofi Present Positive Study Results for Investigational PD-1 Antibody REGN2810 at American Society of Clinical Oncology (ASCO) Annual Meeting

News provided by

Regeneron Pharmaceuticals, Inc.

04 Jun, 2017, 10:00 ET